Structural and functional validation of a highly specific Smurf2 inhibitor.

Area of Science:

• Biochemistry
• Molecular Biology
• Cellular Biology

Background:

• Smurf1 and Smurf2 are HECT E3 ubiquitin ligases crucial for cellular processes, notably TGF-β and BMP signaling.
• E3 ligases are key regulators of protein stability, making them attractive therapeutic targets, yet specific inhibitors are scarce.
• Smurf proteins are implicated in various pathological conditions, highlighting the need for targeted inhibition.

Purpose of the Study:

• To explore ubiquitin variants (UbVs) as potential inhibitors for Smurf1 and Smurf2.
• To identify and characterize a highly specific inhibitor for Smurf2.
• To elucidate the mechanism of inhibition for the identified Smurf2 inhibitor.

Main Methods:

• Screening of ubiquitin variants (UbVs) for binding to Smurf1 and Smurf2.
• In vitro binding and ubiquitination assays to assess inhibitory activity and specificity.
• Orthologous cellular assays to confirm Smurf2 specificity in a cellular context.
• Structural analysis of the inhibitor-target complex.

Main Results:

• A specific Smurf2 inhibitor, UbV S2.4, was identified with high potency (low nanomolar range).
• UbV S2.4 demonstrated high specificity for Smurf2, with no cross-reactivity towards Smurf1 in cellular assays.
• Structural studies revealed UbV S2.4 inhibits Smurf2 by targeting the E2 binding site, disrupting the E2-E3 interaction.

Conclusions:

• UbV S2.4 is a highly specific and potent inhibitor of Smurf2.
• The identified inhibitor provides a valuable tool for studying Smurf2 function and its role in disease.
• Targeting the E2-E3 protein interaction interface is a viable strategy for developing specific E3 ligase inhibitors.